Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in chinese population

Molecular Carcinogenesis

Volumn 52, Issue SUPPL1, 2013, Pages 118-126

  Zhong, Rong ^a   Liu, Li ^b   Zou, Li ^a   Zhu, Yaowu ^a   Chen, Wei ^a   Zhu, Beibei ^a   Shen, Na ^a   Rui, Rui ^a   Long, Lu ^a   Ke, Juntao ^a   Lu, Xuzai ^a   Zhang, Ti ^a   Zhang, Yu ^a   Wang, Zhenling ^a   Liu, Lifeng ^a   Sun, Yu ^a   Cheng, Liming ^a   Miao, Xiaoping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Genetic variation; Lung cancer; TERT CLPTM1L

Indexed keywords

CLEFT LIP AND PALATE TRANSMEMBRANE 1 LIKE PROTEIN; MEMBRANE PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BIOINFORMATICS; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

GENETIC VARIATION; LUNG CANCER; TERT-CLPTM1L;

ADENOCARCINOMA; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SMALL CELL LUNG CARCINOMA; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84886285600     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22043     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
2. Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology 2003; 8:17-21.
3. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003; 362:847-852.
4. Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: Current patterns and data needs. Int J Cancer 2005; 116:963-971.
5. Liu L, Wu J, Wu C, et al. A functional polymorphism (-1607 1G->2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer. Cancer 2011; 117:5172-5181.
6. Liang G, Miao X, Zhou Y, Tan W, Lin D. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking. Carcinogenesis 2004; 25:773-778.
7. Guo H, Deng Q, Wu C, et al. Variations in HSPA1B at 6p21.3 are associated with lung cancer risk and prognosis in Chinese populations. Cancer Res 2011; 71:7576-7586.
8. Broderick P, Wang Y, Vijayakrishnan J, et al. Deciphering the impact of common genetic variation on lung cancer risk: A genome-wide association study. Cancer Res 2009; 69:6633-6641.
9. Hu Z, Wu C, Shi Y, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 2011; 43:792-796.
10. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008; 40:1404-1406.
11. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008; 40:1407-1409.
12. Feldser DM, Hackett JA, Greider CW. Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer 2003; 3:623-627.
13. Weinrich SL, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997; 17:498-502.
14. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
15. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 2001; 280:1148-1154.
16. Moreau Y, Tranchevent LC. Computational tools for prioritizing candidate genes: Boosting disease gene discovery. Nat Rev Genet 2012; 13:523-536.
17. Hsu C-P, Hsu N-Y, Lee L-W, Ko J-L. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter-Effect on telomerase expression and telomere length maintenance in non-small cell lung cancer. Eur J Cancer 2006; 42:1466-1474.
18. Lee PH, Shatkay H. F-SNP: Computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 2008; 36:D820-D824.
19. George Priya Doss C, Sudandiradoss C, Rajasekaran R, et al. Applications of computational algorithm tools to identify functional SNPs. Funct Integr Genomics 2008; 8:309-316.
20. Liang L, Morar N, Dixon AL, et al. A cross-platform analysis of 14, 177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res 2013; 23:716-726.
21. Ellinghaus D, Schreiber S, Franke A, Nothnagel M. Current software for genotype imputation. Hum Genomics 2009; 3:371-380.
22. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125:279-284.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265.
24. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989.
25. Callen E, Surralles J. Telomere dysfunction in genome instability syndromes. Mutat Res 2004; 567:85-104.
26. Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis 2010; 31:9-18.
27. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144:646-674.
28. Kapushesky M, Adamusiak T, Burdett T, et al. Gene expression atlas update-A value-added database of microarray and sequencing-based functional genomics experiments. Nucleic Acids Res 2012; 40:D1077-D1081.
29. James MA, Wen W, Wang Y, et al. Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus. PLoS ONE 2012; 7:e36116.
30. Fachiroh J, Sangrajrang S, Johansson M, et al. Tobacco consumption and genetic susceptibility to nasopharyngeal carcinoma (NPC) in Thailand. Cancer Causes Control 2012; 23:1995-2002.
31. Hofer P, Baierl A, Bernhart K, et al. Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk. Mol Carcinog 2012; 51:E176-E182.
32. Liu Z, Li G, Wei S, et al. Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2010; 31:1977-1981.
33. Shen J, Gammon MD, Wu HC, et al. Multiple genetic variants in telomere pathway genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2010; 19:219-228.
34. Varadi V, Brendle A, Grzybowska E, et al. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer. Cancer Genet Cytogenet 2009; 190:71-74.
35. Soerensen M, Thinggaard M, Nygaard M, et al. Genetic variation in TERT and TERC and human leukocyte telomere length and longevity: A cross-sectional and longitudinal analysis. Aging Cell 2012; 11:223-227.
36. Savage SA, Chanock SJ, Lissowska J, et al. Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer 2007; 97:832-836.
37. Horn S, Figl A, Rachakonda PS, et al. TERT promoter mutations in familial and sporadic melanoma. Science 2013; 339:959-961.
38. Lantuejoul S, Soria JC, Moro-Sibilot D, et al. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 2004; 90:1222-1229.
39. Liu P, Vikis HG, Lu Y, et al. Cumulative effect of multiple loci on genetic susceptibility to familial lung cancer. Cancer Epidemiol Biomarkers Prev 2010; 19:517-524.
40. Wauters E, Smeets D, Coolen J, et al. The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema. Eur Respir J 2011; 38:924-931.
41. Bae EY, Lee SY, Kang BK, et al. Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology 2012; 17:699-706.
42. Landi MT, Chatterjee N, Yu K, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009; 85:679-691.
43. Zienolddiny S, Skaug V, Landvik NE, et al. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 2009; 30:1368-1371.
44. Phillips DH. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 2002; 23:1979-2004.
45. Arif JM, Dresler C, Clapper ML, et al. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens. Chem Res Toxicol 2006; 19:295-299.